XML 35 R96.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combinations - Anandia Laboratories Inc. ("Anandia") (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 11 Months Ended 12 Months Ended
Aug. 08, 2018
CAD ($)
year
shares
day
tranche
$ / shares
Aug. 07, 2018
CAD ($)
Jun. 30, 2019
CAD ($)
Jun. 30, 2020
CAD ($)
Jun. 30, 2019
CAD ($)
Disclosure of detailed information about business combination [line items]          
Consideration transferred     $ 3,181,453   $ 3,181,453
Common shares issued     3,036,810   3,036,810
Share purchase warrants issued     19,565   19,565
Milestone payment expense       $ 10,400 15,100
Final          
Deferred tax liability     (78,551)   (78,551)
Goodwill     2,416,940   2,416,940
Anandia Laboratories Inc. (“Anandia”)          
Disclosure of detailed information about business combination [line items]          
Consideration transferred $ 98,153        
Number of shares issued for acquisition (in shares) | shares 1,059,707        
Common shares issued $ 78,588        
Number of purchase warrants issued (in shares) | shares 529,851        
Share purchase warrants issued $ 19,565        
Exercise price of warrants (in CAD per share) | $ / shares $ 9.37        
Gross contingent consideration accounted for as post-combination services $ 10,000        
Number of tranches to paid out on additional share consideration | tranche 3        
Milestone payment expense       $ 5,400 $ 7,400
Provisional allocation at acquisition          
Intangible assets $ 30,900        
Deferred tax liability (7,422)        
Goodwill 57,595        
Adjustments          
Intangible assets (1,200)        
Deferred tax liability 367        
Goodwill 876        
Final          
Intangible assets 29,700        
Deferred tax liability (7,055)        
Goodwill $ 58,471        
Revenue of combined entity as if combination occurred at beginning of period     3,000    
Loss of combined entity as if combination occurred at beginning of period     $ 6,200    
Revenue of acquiree prior to acquisition date   $ 200      
Loss of acquiree prior to acquisition date   $ 2,500      
Anandia Laboratories Inc. (“Anandia”) | Risk-free interest rate          
Disclosure of detailed information about business combination [line items]          
Significant unobservable input, liabilities 0.022        
Anandia Laboratories Inc. (“Anandia”) | Dividend yield          
Disclosure of detailed information about business combination [line items]          
Significant unobservable input, liabilities 0        
Anandia Laboratories Inc. (“Anandia”) | Historical volatility for shares          
Disclosure of detailed information about business combination [line items]          
Significant unobservable input, liabilities 0.899        
Anandia Laboratories Inc. (“Anandia”) | Volume weighted average price          
Disclosure of detailed information about business combination [line items]          
Significant unobservable input, liabilities 7.13        
Anandia Laboratories Inc. (“Anandia”) | Volume weighted average price, consecutive trading days          
Disclosure of detailed information about business combination [line items]          
Significant unobservable input, liabilities | day 20        
Anandia Laboratories Inc. (“Anandia”) | Term of consideration          
Disclosure of detailed information about business combination [line items]          
Significant unobservable input, liabilities | year 4